MAPT and diabetes mellitus: Thus, metformin attenuates diabetes-induced tau hyperphosphorylation by enhancing autophagic clearance [75], it reduces tau hyperphosphorylation, attenuating tau pathology and improving learning and memory deficits in the tau-seeded PS19 [76], and attenuates plaque-associated tau pathology in APP/PS1 mice [77].